9- PHARMA MULTI-C...
Follow
Find
31.3K views | +148 today
 
Rescooped by Lionel Reichardt / le Pharmageek from 1- E-HEALTH by PHARMAGEEK - E SANTE par PHARMAGEEK
onto 9- PHARMA MULTI-CHANNEL MARKETING by PHARMAGEEK
Scoop.it!

Content Marketing & Pharmaceutical Industry : what is the best process ?

Content Marketing & Pharmaceutical Industry : what is the best process ? | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it


According to  Buddy Scalera, (Senior VP Ogilvy CommonHealth Interactive Marketing), content travels across multiple platforms, so it should be developed and delivered in a way that is “platform-agnostic.” Strategic goals for content must be aligned to move people through the sales funnel or consideration process. Audit analysis must be conducted to determine if gaps exist.


Content should be personalized. Content creation should be a multi-phase process: Ask a lot of questions, figure out what your customers want, determine what already exists, think like a publisher, and make it part of your process.


Content is more than text and is not always consumed the way you think. Content is not limited; data the audience wants to consume on their mobile devices is different from what they want on their computers.


Original source : http://contentmarketinginstitute.com


Via Philippe Marchal/Pharma Hub, Lionel Reichardt / le Pharmageek
more...
No comment yet.
9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK
MULTI CHANNEL MARKETING IN PHARMA / MULTICANAL DANS LA PHARMA
Your new post is loading...
Your new post is loading...
Rescooped by Lionel Reichardt / le Pharmageek from Pharma Multichannel Marketing
Scoop.it!

Sanofi joins WHO-backed diabetes mHealth programme

Sanofi joins WHO-backed diabetes mHealth programme | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Becomes
sole pharma partner for Be Healthy, Be Mobile's diabetes arm

Via Stephen Dunn
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Innovation, Big Data, Open Data, Internet of Things, Smart Homes & Cities, 3D printing
Scoop.it!

France : des hackathons pour concevoir des objets connectés | Proxima Mobile : applications et services gratuits sur mobile pour les citoyens

France : des hackathons pour concevoir des objets connectés | Proxima Mobile : applications et services gratuits sur mobile pour les citoyens | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Portail des applications et de services aux citoyens sur téléphone mobile, coordonné par la Délégation aux usages de l'Internet (Ministère de la Recherche / Ministère de l'Industrie) .

Via Celine Sportisse
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Digital Revolution, Digital Health, Internet Psychology, Wellness & IoT
Scoop.it!

80% Of All Online Adults Now Own A Smartphone, Less Than 10% Use Wearables

80% Of All Online Adults Now Own A Smartphone, Less Than 10% Use Wearables | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
If people are looking to Apple and its new smartwatch to kickstart wider consumer interest in wearable computing gadgets, the maker of the iPhone will..

Via Raphaelle LAUBIE
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Social Media and Healthcare
Scoop.it!

FDA Readies Social Media Rules For Big Pharma

FDA Readies Social Media Rules For Big Pharma | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it

Social media plays an increasingly important role in the marketing and communications plans for pharmaceutical firms.

Trends point to patients and healthcare professionals using social media to research, communicate and influence buying decisions. There are already examples of pharmaceutical firms who are already successfully using social media.

However, many firms have been waiting on the sidelines waiting for guidance from the regulator, the Food and Drug Administration (FDA).

In response to the industry’s request for guidance, the FDA has been busy coming up with some. Over the last 6 months, it has released 3 draft guidance documents for social media.

This is a fast-changing situation with the FDA widely expected to release final guidance on social media very soon.

Acknowledging the keen interest in this area, on July 10th the FDA delivered “The Social Media Draft Guidance Webinar”. The slides for the webinar are available on the FDA’s website.

There are a few recurring points running through all the pieces of FDA guidance, namely:

  • Communications must be balanced, accurate and non-misleading
    • The closer to the creation or adoption of the content, the more likely a firm is responsible for that content.
    • There is no “one-click rule”.  Risk information should be given equal prominence to benefit information, regardless of space constraints.
    • Direct hyperlinks to risk information and/or FDA approved labeling may to be provided from the message, update, ad or tweet as a means to learn more about the product.
  • Organizations must capture and preserve full and proper records
    • Social media communications need to be properly retained, preferably in context, in a format that preserves interactive links
    • Full metadata such as author, date, etc., also needs to be archived

What is clear is that the FDA means business when it comes to the conduct of pharmaceutical firms on social media.  Firms can expect to be held accountable if these standards are not met. Even before the draft guidelines were released, the FDA already demonstrated that it is closely monitoring pharmaceutical firm’s use of social media.  This is illustrated by the warning letters issued to firms it believed had used social media inappropriately, for example:

With the key guidance on the use of social media from the FDA widely expected to be finalized in soon, there is a real likelihood that the FDA will increasingly step up its monitoring program and impose sanctions on non-compliant firms.

However, in response to this recent guidance, we may begin to see more firms explore how they can use social media to build brand awareness, facilitate communities, even drive revenues. These firms need to take thoughtful steps in order to deploy social media compliantly, including, making sure communications are balanced, accurate and non-misleading as well as taking steps to monitor and preserve real-time communications.

Check out these compliant social media guidelines from the FDA:

  1. Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices (December 2011)
  2. Fulfilling Regulatory Requirements for Postmarking Submissions of Interactive Promotional Media for Prescription Human and Animal Drugs and Biologics (Draft Jan 2014, Final expected July 2014)
  3. FDA Draft Guidance for Industry Internet/Social Media Platforms with Character Space Limitations – Presenting Risk and Benefit Information for Prescription Drugs and Medical Devices (June 2014)
  4. FDA Draft Guidance for Internet/Social Media Platforms: Correcting Independent Third-Party Misinformation About Prescription Drugs and Medical Devices (June 2014)



Via Plus91
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Pharma Multichannel Marketing
Scoop.it!

2015 #ePharma Summit highlights, Day Two

2015 #ePharma Summit highlights, Day Two | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Here are some of my personal highlights from day two of the 2015 #ePharma Summit. The ePharma Summit connects pharmaceutical biotech and medical device marketers in bringing together brands, HCPs, and consumers in the era of digital marketing.

Via Stephen Dunn
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Strategy and Competitive Intelligence by Bonnie Hohhof
Scoop.it!

Digital business era: stretch your boundaries – Accenture Technology Vision

Digital business era: stretch your boundaries – Accenture Technology Vision | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it

Today’s pioneering enterprises are doing more than just talking a good digital game. They are fundamentally changing the way they look at themselves and quickly mastering the shift from “me” to “we.”
Proactive corporate leaders see their businesses, employees and customers as a living, breathing digital fabric offering unprecedented opportunity to establish beachheads in new markets, drive profit and change life for the better. Through the transformational power of this network, we’re witnessing the birth of a new era of “digital ecosystems.


Via Bonnie Hohhof
more...
Rescooped by Lionel Reichardt / le Pharmageek from Pharma Hub
Scoop.it!

Trend: Taking health (and brain health) care "beyond the pill"

Trend: Taking health (and brain health) care "beyond the pill" | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
. How Device Makers Can Take Healthcare "Beyond the Pill" (Medical Device and Diagnostic Industry): "One thing is clear: Pharma’s commitment to “beyond the

Via Philippe Marchal/Pharma Hub
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Pharma: Trends in e-detailing
Scoop.it!

Major cuts coming to Pharma's business-side workforce

Major cuts coming to Pharma's business-side workforce | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
A major change now taking place means that within a decade, most of the industry's business-side positions will be gone and those communities will look altogether different, at least as far as the occupations of their residents.

Via eMedToday
more...
Alexandre Gultzgoff's curator insight, February 24, 12:40 PM

interesting analysis of pharma moving from B2B  to a B2C model in coming years

Rescooped by Lionel Reichardt / le Pharmageek from Pharma
Scoop.it!

The five Ws of health message design

The five Ws of health message design | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it

Click here to edit the title


Via Andrew Spong
more...
Andrew Spong's curator insight, February 19, 11:17 AM

Excerpted from the World Innovation Summit for Health 2015 report (p.13), available as a free download (without a data scrape) here:

 

http://dpnfts5nbrdps.cloudfront.net/app/media/1426

 

See also #WISH2015

Rescooped by Lionel Reichardt / le Pharmageek from Social Media and Healthcare
Scoop.it!

Top World 12 Pharmaceutical companies on Social Media

Top World 12 Pharmaceutical companies on Social Media | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it

We present you our last report about Pharmaceutical Companies taking into account their global profiles on Social Media during December 2014. The analysed companies have been selected regarding their turnover volume, and are the following :GlaxoSmithKline, Astrazeneca, Novartis, Pfizer, Sanofi, Johnson & Johnson, Merck, Roche, Eli Lilly, Bristol MyersSquibb, Abbott and Bayer.

Among the 12 enterprises considered for the study, Facebook is the most important social network with 2 millions of potential buyers. The most populars companies are Bayer and Johnson & Johnson because they gather the 80% of the total unique audience.

Twitter is the place where pharmaceutical brands are more active, in spite of their performance not being very high (an average of 78 tweets/month) in comparison with other industries’ activity on this social network.

Pharmaceutical Companies obtain the best results of engagement on Youtube. This network should be part of your online strategy. Johnson & Johnson has the 44% of the total unique users, meaning that it holds almost half of the market.

Would you like to know more about this study? If so, please click on the button bellow these lines and you will find out interesting data for your knowledge.



Via Plus91
more...
Tanya Kerr's curator insight, February 22, 9:25 PM

Interesting to see the stats on usage of social media by the pharmaceutical industry.

Rescooped by Lionel Reichardt / le Pharmageek from education du patient
Scoop.it!

Mobile phone in asthma management and control through “myAirCoach” project

Mobile phone in asthma management and control through “myAirCoach” project | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
European researchers have been awarded over €4.5 million to create a user-friendly tool for asthmatic patients to monitor and self-control their disease. The myAirCoach project will run for three years and involves numerous research centers in EU.

The name of the project, myAirCoach, stands for analysis, modeling and sensing of both physiological and environmental factors for asthma’s customized and predictive self-management, and seeks to merge mobile health potential to improve the quality and efficiency of healthcare with the daily needs of chronic asthma patients.

European Federation of Allergy and Airways Diseases Patients’ Associations (EFA) is one of the main partners in the project.

Via Dominique Godefroy, Marie Françoise de Roulhac
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Social Media and Healthcare
Scoop.it!

Why Pharma must provide HCPs with relevant digital tools

Why Pharma must provide HCPs with relevant digital tools | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it

Mega Trend #9: The Majority of HCPs are now Digital Natives; and they Expect Pharma to Follow

HCPs are typically on the go all day – exam rooms, offices, surgery – so their time online is limited. That said, they are anxiously seeking better information on clinical studies and evidence-based medicine. In fact, 81% of physicians in the SERMO survey want higher quality pharma representatives capable of having serious discussions of “multiple therapeutic options.”1

Taking the time to understand physicians’ primary needs – helping their patients be healthy, sharing knowledge with peers, making a good living, keeping themselves up-to-date on clinical and therapeutic developments – provides opportunities for pharma to facilitate these needs and help physicians accomplish their goals. Leveraging digital health as part of that mission can tap into each of those key HCP needs and open doors for pharma firms.1, 2

At the same time, digital poses a “triple-threat” to the autonomy of HCPs. Patients access digital channels, particularly social media, as a primary source for disease and treatment information, subplanting the authority that used to belong to the GP. Pharmaceutical companies, while reluctant to enter the market with end-to-end direct online solutions, could cause income losses for doctors working outside of hospital settings by becoming direct competitors for their patients. And nurses have taken increasing roles in patient care, using digital assets, websites and apps from pharma and other sources as adherence tools and to improve their interactions with patients.2, 3, 4, 5

While not as active as patients online, 2014 will present a tipping point for HCP digital engagement, with 51% becoming “digital native.” More HCPs will get medical news, reference material and textbooks, receive CME credits and visit virtual conferences online than ever before.6 When asked what digital channels they preferred, HCPs cited a broad variety, from social media to mobile apps to independent medical websites. They also noted that pharma reps remain a key source of critical information.7 Finally, more than 80% of HCPs have a desktop/laptop computer and a smartphone, and 72% own a tablet.6  Mobile assets are rapidly becoming components in the clinical environment.

Pharma must reach out to HCPs and provide relevant digital tools, content and communities that help them do their jobs more effectively.

The trend is a product of an evidence-based research study undertaken by the Healthcare Division in Valtech to map the pharmaceutical landscape of digital mega trends. The research study provides essential insights on how Pharma companies could utilize digital engagement to break down stakeholder barriers, impact stakeholder behaviour and demonstrate more cost-effective outcomes. The research study is based on information from 100+ trusted sources and has resulted in the identification of 14 mega trends.

REACH OUT TO GAIN AN UNDERSTANDING OF HOW TO EXECUTE ON THE UNDERUSED DIGITAL OPPORTUNITIES

The Healthcare Division in Valtech has developed an analytical framework that can identify the engagement potential of your brand. The analysis will provide you with answers to the following questions:

  • WHY should your product or therapeutic area have a relevant presence in a digital context?
  • WHO should your digital value proposition appeal to/engage and for what reasons?
  • WHAT changes in the stakeholder’s awareness/behaviour should the digital engagement enable?
  • WHEN during the patient pathway should the digital engagement take place?
  • WHERE – in which healthcare environment/context – should the digital engagement take place?
  • HOW should digital engagement be optimized via the utilization of state of the art digital assets?
  • What metrics should be implemented to measure IF digital engagement is successful?

Please contact Senior Digital Pharma Advisor Rasmus Rask for further advice or to set up an informal meeting.

If you want to read more about Mega Trend #9 you can download more information on valtech.dk.

Stay tuned for the upcoming blog post on Mega Trend #10: Pharma Must Deliver a Seamless Cross-channel Experience When, Where and How the HCPs Want it. And make sure you did not miss the previous blog posts on pharmaceutical mega trends:

Mega Trend #1: Pharmaceutical CEOs Lack Confidence to Act
Mega Trend #2: Transforming to a Digital Business: A Fundamental Paradigm Shift
Mega Trend #3: The “Trust” Gap: Leveraging Digital to Reconnect with Stakeholders
Mega Trend #4: Reinventing the Marketing Function for a Digital Environment
Mega Trend #5: Follow the 20-20-20 Rule for Digital Budgets
Mega Trend #6: Big Data, Mobile and Social Create a More Level Playing Field; Pharma is Slow to Respond
Mega Trend #7: In the New Era of Quantified Self, Patients Want Pharma on Their Side
Mega Trend #8: Achieving Long-term, Sustainable Growth Starts with Meeting Patient Expectations

Sources:
1. Publicis Healthcare Communications Group. Publicis Touchpoint Solutions, Inc. (2012). What Physicians Want! www.publicishealthcare.com
2. Bain and Company. Chuck Fargas et. al. (2012). The future of healthcare—there’s an app for that. www.bain.com
3. T. Kearney. Oliver Scheel et. al. (2013). Mobile health: Mirage or growth opportunity? www.atkearney.com
4. Vertic healthcare. Mads Krogh Petersen (2013). How Digital is Reinventing Everything in the Healthcare Industry www.vertic.com
5. Manhattan Research. Monique Levy et. al. (2014). Pharma Multichannel Marketing Outlook: 14 Trends to Drive Growth in 2014. www.manhattanresearch.com
6. Manhattan Research. Unknow Author. (2013). Taking the pulse 2013. www.manhattanresearch.com
7. Capgemini. Tim Moore et. al. (2012). Multichannel Closed Loop Marketing. Digitally Transforming the Life Sciences Industry. www.capgemini.com



Via Plus91
more...
Alexandre Gultzgoff's curator insight, February 23, 3:32 AM

WHY should your product or therapeutic area have a relevant presence in a digital context?

WHO should your digital value proposition appeal to/engage and for what reasons?WHAT changes in the stakeholder’s awareness/behaviour should the digital engagement enable?WHEN during the patient pathway should the digital engagement take place?WHERE – in which healthcare environment/context – should the digital engagement take place?HOW should digital engagement be optimized via the utilization of state of the art digital assets?What metrics should be implemented to measure IF digital engagement is successful?
Scooped by Lionel Reichardt / le Pharmageek
Scoop.it!

SOCIAL MEDIA MONITORING : L'ECOUTE DU WEB POUR LA PHARMA #hcsmeufr

1 recherche sur 20 faite sur Google concerne la santé..25 % des conversations sur les réseaux sociaux aussi.. des milliards d'informations qui pourraient en di…
more...
Alexandre Gultzgoff's curator insight, February 20, 1:07 PM

qqs slides bien intéressantes a la fin de la pres...

Scooped by Lionel Reichardt / le Pharmageek
Scoop.it!

New Pharma Digital Marketing Benchmarks Show that Online Pharmaceutical Marketing Continues to Drive Brand Awareness, Favorability and Conversions

New Pharma Digital Marketing Benchmarks Show that Online Pharmaceutical Marketing Continues to Drive Brand Awareness, Favorability and Conversions | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
comScore, Inc. (NASDAQ: SCOR), a leader in measuring the digital world, today released results from its eighth annual Online Marketing Effectiveness Benchmarks for the Pharmaceutical Industry, conducted in partnership with marketing innovation consultancy Evolution Road LLC.
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Health, Digital Health, mHealth, Digital Pharma, hcsm latest trends and news (in English)
Scoop.it!

Pharma Marketing Blog: Impact of mHealth on Adherence and Patient Outcomes Needs Improving. How "Open, Crowdsourced" Data from Pharma Can Help

Pharma Marketing Blog: Impact of mHealth on Adherence and Patient Outcomes Needs Improving. How "Open, Crowdsourced" Data from Pharma Can Help | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it

Via Celine Sportisse
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from [Pharma & Life sciences: patient-centricity and direct communication to patients - Precision medicine - Patient-focused drug development - Pharma multichannel communication & marketing to healthcare profesionnals] by VAB Traductions
Scoop.it!

Clinical Trials - Pharma in the Twittersphere

Clinical Trials - Pharma in the Twittersphere | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it

"Social media can contribute to nearly every aspect of a clinical trial, from development and recruitment, to sharing important information and findings with patients and researchers. Twitter, in particular, provides the public with a free flow of information and open sharing of ideas, and has been used extensively by patients looking for alternative treatment options. We investigate the unique opportunities provided by Twitter for clinical trials."


Via Plus91, VAB Traductions
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Doctors Hub
Scoop.it!

Poll shows all ages seek digital health tools

Poll shows all ages seek digital health tools | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Millennials and baby boomers have a lot of common a desire for technology that supports health priorities.

Via eMedToday, Philippe Marchal/Pharma Hub
more...
Tanya Kerr's curator insight, February 27, 6:39 PM
Good article that shows the disease or condition is more important motivator. Also that the type of digital media preferred is different per age group.
Rescooped by Lionel Reichardt / le Pharmageek from Pharma Multichannel Marketing
Scoop.it!

Study: Physician social networks may be more effective than medical journals

Study: Physician social networks may be more effective than medical journals | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Researchers have found that social physician networks may be more influential than traditional medical journals.

Via Stephen Dunn
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Social Media and Healthcare
Scoop.it!

3 Reasons Why Digital Matters in Healthcare Marketing

3 Reasons Why Digital Matters in Healthcare Marketing | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it

Everywhere you turn, digital dominates. Articles across the Web proclaim its importance in marketing strategies, and now, digital marketing is unavoidable. Why? Its benefits and ease of use are too great to ignore. But let’s get a little more specific. When it comes to healthcare marketing, why does digital matter?

In this article, we’ll discuss three key benefits of integrating digital marketing into your promotional strategy taking into account customer demands of the healthcare sector.

Before we get started, take a look at these impressive statistics:

  • 77% of online health seekers say they began their last session at a search engine such as Google, Bing, or Yahoo
  • 51% of patients say they’d feel more valued as a patient when doctors use social media, blogs, and other digital engagement outlets
  • 72% of internet users say they looked online for health information within the past year
  • Behind using search engines and checking email, the #3 activity people do online is search for health information

Customers and potential clients demand your presence on digital channels, but what’s in it for you as a healthcare marketer?

OPTIMIZED PROGRAMS

Unlike traditional marketing channels, digital marketing allows for the optimization of individual campaigns while the programs are live. Instead of sending out one message to a broadly targeted audience in say, a television, newspaper or radio ad, you can tailor your messaging according to keywords, devices, interests, locations, demographics and more. Digital programs also give advertisers the ability to adjust targeting techniques at any time. For example, a company started a marketing campaign to target woman age 30-50 for their cosmetic procedure. Shortly after the campaign launched, the company realized a better target for their procedure is males over the age of 65. Unfortunately the company has already bought TV and Radio ads on stations targeting women. Digital platforms allow companies to adjust their target criteria in real-time so that there is no wasted budget. Much like an investment portfolio, digital channels allow advertisers to "invest" budget in areas that perform and eliminate underperforming campaigns. Does radio, print or TV provide that capability? Once an ad is printed, filmed or recorded, there is no opportunity to make improvements or adjustments.  

Your audience is online, and as such, you should already be engaged in digital marketing. At the very least, you should be strongly considering adopting a digital strategy. Google Think surveys found that 76% of patients were using hospital websites for research, compared to 32% using TV, 20% using magazines and 18% using newspapers.

With the ability to closely monitor digital campaigns and act on real-time metrics and feedback, medical marketers can see better returns on investment.

MOBILE TARGETING

The mobile market is growing at an incredible rate. In fact, this year eMarketer predicts that worldwide smartphone penetration will reach two billion. Google research has already found that roughly 1/3 of patients use tablets or mobile devices on a daily basis for research and/or to book appointments.

The statistics below only go to show mobile’s rising prominence in the healthcare industry:

  • Of patients who found physicians and private practices on their mobile devices, 44% scheduled an appointment (Source)
  • Year-over-year (2012-13) the number of consumers using mobile devices to search for healthcare services increased 22% (Source)
  • 52% of smartphone users gather health-related information on their phones (Source)

You’ve no doubt figured out by now that mobile should be a priority when it comes to your healthcare digital marketing strategy. Luckily, most digital marketing platforms will allow you to target users by device. Just make sure that your ads and landing pages are optimized for mobile devices, or you may end up doing more harm than good.

PROGRAM FLEXIBILITY

As part of the healthcare industry, you know that in any situation, everything can change at the drop of a hat. New market research makes your campaign irrelevant? Marketing budgets get slashed? Management isn’t sold on your execution strategy? This can mean big trouble if you’re dealing with prepaid campaigns and/or advertising programs that can’t be paused immediately.

With digital marketing campaigns, these crises are easily averted. The freedom and flexibility offered by digital advertising methods are invaluable! There’s no need to pay weeks or even months in advance, and you have complete control with the ability to turn these programs on/off with the click of a button.

Healthcare digital marketing is no longer a suggestion. It’s a requirement. Customer demand for digital is constantly growing and the benefits of a digital strategy far outweigh its disadvantages. At this point, it’s a no brainer. Digital marketing matters, and in order for your healthcare practice to be successful, you’ll need to meet patients where they are: online.



Via Plus91
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Doctors Hub
Scoop.it!

Impact of mHealth Chronic Disease Management on Treatment Adherence and Patient Outcomes: A Systematic Review

Impact of mHealth Chronic Disease Management on Treatment Adherence and Patient Outcomes: A Systematic Review | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it

A systematic review of the literature to evaluate the effectiveness of mHealth in supporting the adherence of patients to chronic diseases management


Via Philippe Marchal/Pharma Hub
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Pharma & Medical Devices
Scoop.it!

Why Big Pharma Must Cure Its Bad Rap

Why Big Pharma Must Cure Its Bad Rap | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
VideoThe 2015 Harris corporate reputation poll is out and the news for Big Pharma isn’t good, to say the least.  In the poll—which measures the “reputation quotient” of the most visible American companies among the general public—Big Pharma ranked ninth out of 14 industries and was right in line with [...]

Via Richard Meyer
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from e-Santé Marketing Santé innovant
Scoop.it!

Apnée du sommeil: les pneumologues et les patients lancent un projet participatif sur la télémédecine

Apnée du sommeil: les pneumologues et les patients lancent un projet participatif sur la télémédecine | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it

La Fédération française de pneumologie (FFP) et celle des associations et amicales d'insuffisants respiratoires (FFAAIR) ont lancé un projet participatif afin de proposer de nouvelles modalités pour la télésurveillance des patients traités par pression positive continue (PPC) pour un syndrome d'apnées hypopnées obstructives du sommeil (SAHOS), à partir notamment des études Optisas, a-t-on appris au Congrès de pneumologie de langue française (CPLF) qui se tenait fin janvier à Lille.


Via Philippe Marchal/Pharma Hub, Dominique Godefroy
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Biotech, Pharmas and ideas
Scoop.it!

Despite Big Pharma Retreat, R&D Spending Advances

Despite Big Pharma Retreat, R&D Spending Advances | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Actavis CEO and president Brett Saunders raised eyebrows a few weeks back when he bluntly stated what a growing number of biopharma chief executives appear to be thinking when it comes to the value of internal R&D.

Via Herve Ansanay
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from education du patient
Scoop.it!

A Review of Corporate Websites in Pharma

A Review of Corporate Websites in Pharma | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Vertic’s review of 12 corporate websites showed an overwhelming internal focus at pharmaceutical companies as they communicate to the outside world. However, a few players have taken significant steps towards walking- the-talk on patient centricity and broader inclusion of the remaining stakeholders in the healthcare eco-system. Tone of voice, design choices and user experience are fragmented and often inspired by best practices from the period between 2009 and 2011. In conclusion, there is a big opportunity for industry players to step up and embrace modern, digital communication.

Via Dominique Godefroy, Marie Françoise de Roulhac
more...
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
Scoop.it!

Social Media Monitoring pour la #Pharma (with images, tweets) · lionelreichardt

#rcsasso - tweets, pics & video - 12 février 2015
more...
No comment yet.